TECH · NASDAQ · STOCK
Bio-Techne (TECH) Stock Analysis
$72.47
52W $43.20 – $72.69
57/100
$11.34B
61.9
1.29
Is TECH Bullish or Bearish?
Mixed.
Innellis AI committee rates Bio-Techne (TECH) Watch with a composite score of 57/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.07 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.93 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.09) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- EPS growing 158.9% YoY — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.09) -- balance sheet can absorb a shock — Risk
Bear Case
- P/E of 62.5 is expensive by classic value standards — Value
- Price-to-book of 5.2x prices in significant intangible value — Value
- Revenue declining -0.4% YoY -- this is not a growth story right now — Growth
- 2 consecutive earnings misses -- execution concerns — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
57/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 51%
of 192 Healthcare peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 62.5 is expensive by classic value standards
Growth Analyst
bearish
39
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ EPS growing 158.9% YoY
− Revenue declining -0.4% YoY -- this is not a growth story right now
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
75
/ 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.09) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 56.9 to 56.9.
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
50.5
Neutral
MACD Histogram
-0.038
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$56.60
Resistance
$72.61
Bollinger %B
0.53
Inside Bands
Price vs Moving Averages
EMA 9
$72.48
Below
EMA 21
$72.43
Above
EMA 50
$71.36
Above
EMA 200
$64.24
Above
Fundamental Analysis
Valuation
47
Growth
38
Profitability
71
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
61.9×
P/B Ratio
5.36×
PEG Ratio
0.40
Dividend Yield
0.44%
52W High
$72.69
52W Low
$43.20
Quality & Growth
ROE
862.6%
ROA
678.8%
Gross Margin
6576.5%
Operating Margin
2073.1%
Revenue Growth YoY
—
Debt / Equity
0.14
AI Fundamental Assessment
P/E ratio of 61.9 (rich relative to a 15-40x range); Price-to-book of 5.4x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.6%; Return on assets of 6.8%; Net margin of 15.0%; Gross margin of 65.8%; Current ratio of 4.55 (healthy short-term liquidity); Debt-to-equity of 0.14; Free cash flow per share is positive (1.69); Most recent quarter missed estimates by 1.8%; 2 consecutive earnings misses; EPS growth decelerating (+15.2% -> -1.9% QoQ); Average YoY EPS growth of -1.9%; Analyst estimates rising over recent quarters
Get the Full TECH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →